The number one question people have after starting a GLP-1 medication — or while deciding whether to start — is: how fast will this actually work?

The honest answer: slower than you want at first, then faster than you expect, then it levels off by design. Here's the full timeline, based on clinical trial data and real-world experience, broken down month by month.

The Big Picture First

In the STEP 1 trial (semaglutide 2.4mg, 68 weeks), the average weight loss curve looks like this:

  • Months 1-3: Gradual ramp as dose increases. Approximately 5-6% body weight lost.
  • Months 3-9: Steepest loss. This is where the magic happens. Another 6-8% comes off.
  • Months 9-15: Loss continues but slows. The curve flattens toward the final average of ~15%.
  • After month 15: Most people have reached or are approaching their plateau — the weight stabilizes at the new lower point.

For tirzepatide (SURMOUNT-1), the curve is similar in shape but steeper — reaching up to 22.5% at 72 weeks at the highest dose.

Now let's break this down into what each month actually feels like.

Month 1: The On-Ramp

Typical loss: 3-5 lbs (1-2% body weight)

You're on the starting dose. Your body is adjusting. Appetite is somewhat reduced but not dramatically. You might feel some nausea, especially in the first week after injection. This is the month where most people wonder, "Is this even working?"

It is. The starting dose is about tolerability, not maximum effect. You're building the foundation. For a complete guide to what happens in the first four weeks, see what to expect your first month on GLP-1.

Month 2: The First Dose Increase

Typical loss: 5-8 lbs cumulative (2-4% body weight)

Your provider will increase your dose at week 4 or 5. After the bump, you'll likely notice a more pronounced appetite reduction. The "food noise" effect — where thoughts about eating become much quieter — often kicks in more noticeably at this dose level.

Side effects may briefly return or intensify for a few days after the increase, then settle. This pattern repeats at each dose escalation: a brief adjustment, then equilibrium.

You might start noticing your clothes fitting differently, even if the scale hasn't moved dramatically. Early weight loss tends to include water weight and visceral fat — the fat around your organs — which doesn't always register visually but does change how things fit around your midsection.

Month 3: The Turning Point

Typical loss: 10-15 lbs cumulative (5-7% body weight)

This is when most people mentally shift from "trying something" to "this is actually working." You're approaching or reaching the therapeutic dose. Appetite suppression is significant. You're eating less without white-knuckling it.

Key milestone: At 5% body weight loss, clinical benefits start appearing — improved blood sugar levels, lower blood pressure, reduced inflammation markers. Your doctor may notice improving lab values even before the visual changes are dramatic.

This is also typically when other people start noticing. The first comments tend to be about your face — the jawline and cheekbones become more defined as facial fat reduces. "Have you been working out?" is a common early signal.

Months 4-6: The Acceleration

Typical loss: 18-28 lbs cumulative (8-12% body weight)

You're on or near the full therapeutic dose. The weight is coming off steadily — roughly 1-1.5% of body weight per week at peak effectiveness. This is the period where the before-and-after photos start looking dramatically different.

Changes you can expect:

  • Visible face changes — sharper jawline, more defined cheekbones, thinner neck
  • Clothes no longer fit — you're likely down 1-2 clothing sizes
  • Waist reduction — typically 2-4 inches by this point
  • Improved energy — many people report feeling lighter and more energetic in daily activities
  • Compliments become frequent — this is the "what are you doing?!" phase

Important note: This is also when you need to be most intentional about protein intake and exercise. At higher rates of weight loss, your body can lose muscle along with fat. Aim for at least 0.7-1g of protein per pound of goal body weight daily, and incorporate resistance training if you're able. This is one of the most important things you can do to ensure the weight you lose is fat, not muscle.

Months 7-9: Continued Progress, Slower Pace

Typical loss: 28-38 lbs cumulative (12-16% body weight)

The rate of loss begins to slow. This is completely normal — it's not a plateau, it's the expected deceleration as you weigh less (a lighter body burns fewer calories) and as your body adapts to the medication.

Psychologically, this period can be tricky. You've gotten used to the scale dropping consistently, and the slower pace can feel discouraging. Remind yourself: you're still losing. The curve in every clinical trial shows continued loss through this period — it's just not as steep.

This is a good time to check in with your provider about dose optimization. Some people benefit from a dose increase if they haven't reached the maximum. Others are well-served staying at a mid-range dose with fewer side effects.

Months 10-12: Approaching the Plateau

Typical loss: 35-45 lbs cumulative (14-19% body weight)

Most people are approaching their maximum weight loss on the medication. The rate slows to perhaps a pound every week or two. Your body is finding a new equilibrium — a set point where the medication's effects balance against your body's adaptive mechanisms.

For reference, the STEP 1 trial showed the average participant reached approximately 15% total body weight loss by week 68 (about 15.5 months). The SURMOUNT-1 trial showed up to 22.5% at 72 weeks for the highest tirzepatide dose. Individual results vary widely — some people exceed these averages significantly, others fall below.

The Plateau: Why It's Not a Problem

When the scale stops moving, it doesn't mean the medication "stopped working." It means your body has reached a new, lower equilibrium. The medication is still active — it's what's keeping you at this lower weight. Without it, the weight trends upward (the STEP 1 extension data showed participants regained roughly two-thirds of lost weight within a year of stopping).

The plateau is the destination, not a failure. You've lost 15-22% of your body weight. Your metabolic markers have improved. Your cardiovascular risk is lower. The maintenance phase is a feature, not a bug.

When Will Other People Notice?

This depends on your starting weight and where you carry fat, but general patterns:

  • 5-8% loss: People close to you notice. "You look different, did you change something?"
  • 10-12% loss: Acquaintances notice. Compliments become common.
  • 15%+ loss: Everyone notices. People who haven't seen you in a while may not recognize you immediately.

Face changes are noticed first (usually around month 3), followed by midsection changes (months 4-6), followed by overall frame changes (months 6+). For a detailed look at how different amounts of loss change your appearance, see our article on what GLP-1 weight loss actually looks like.

Why 68 Weeks Is the Number That Matters

You'll see "68 weeks" referenced constantly in GLP-1 research. That's the duration of the STEP 1 trial — approximately 15.5 months. It's the timeframe for which we have the most robust data on both efficacy and safety.

This doesn't mean you should stop at 68 weeks. It means: if you're six weeks in and feeling impatient, you're comparing yourself against a benchmark that took over a year to achieve. Give the process time. The data says it works — but it works on a timeline measured in months, not weeks.

Visualize Your Timeline

Want to see what the endpoint looks like? The MeOnGLP transformation tool uses your actual height, weight, age, and sex to project what you'd look like at your expected GLP-1 weight loss — including the specific numbers for pounds lost, BMI change, and estimated waist reduction. It takes 60 seconds and gives you a concrete visual target for the journey ahead.